Abstract image showing various gray dots connected by lines

Clinical evidence

Mo.Ma™ Ultra proximal cerebral protection device

View clinical evidence for the Mo.Ma™ ultra proximal cerebral protection device.

ARMOUR trial 30-day all stroke rate of 2.3%

The Mo.Ma™ Ultra proximal cerebral protection device was evaluated in the ARMOUR trial,¹ a multicenter clinical study, during carotid artery stenting of a total of 262 high surgical risk patients with critical artery stenosis. The ARMOUR trial primary endpoint (MACCE) was a composite endpoint of any myocardial infarction, stroke, or death at 30 days post-procedure. The primary endpoint analysis was based upon 220 evaluable intent-to-treat (ITT) patients.

ARMOUR trial 30-day primary endpoint

30-day event rates 220 patients (ITT)

Related links

Ansel GM, Hopkins LN, Jaff MR, et al. Safety and effectiveness of the INVATEC Mo.Ma™ proximal cerebral protection device during carotid artery stenting: results from the ARMOUR pivotal trial. Catheter Cardiovasc Interv. 2010;76(1):1–8.

First Name

Last Name

First Name

Last Name

Hospital Or Organization

Job Role

Specialty

MESSAGE

I have read and agree to the terms and conditions.

Your information will be used and protected in accordance with our {link}

United States

Customer Care Team

Hours: 8:00 a.m. - 8:00 p.m. EST

Phone: 763-514-4000

Toll-free: 800-633-8766

Confirm country/region

Just to confirm, is this the product or product type that interests you?

{{productNamePlaceholder}}

Confirm country/region

Before we get started, what best describes you?

Confirm country/region

Before we get started, what best describes you?

Message

First Name

Last Name

Hospital Or Organization

HOSPITAL POSTAL CODE

Job Role

Specialty

First Name

Last Name

PHONE

Hospital Or Organization

HOSPITAL POSTAL CODE

Job Role

Specialty

{{productNamePlaceholder}} New products & technology New services Education & training Clinical information Customer Experience Surveys

If you subscribe to email updates, you can unsubscribe anytime via the link in each email. We use technology to measure email opens and clicks, to improve our communications and provide relevant content. For details, see our {link}

I have read and agree with the terms and conditions.

Your personal data will be used to manage your relationship with Medtronic in accordance with our {link}

Before we get started, what best describes you?

First Name

Product & technology information Education & clinical information

Customer experience surveys

If you consent to receive emails, you can unsubscribe anytime via the link in each email. We use technology that measures email opens and clicks, to improve our communications and provide relevant content. For details, see our {link}